Prognostic significance of GDF 15 and NTproBNP levels and echocardiographic parameters in patients with heart failure with preserved ejection fraction and asymptomatic diastolic dysfunction after myocardial infarction on the background of arterial hyperte
Aim. Chronic heart failure with preserved ejection fraction is related to syndromes with a poor prognosis. 93 patients with preserved left ventricular ejection fraction (EF>45%) after myocardial infarction on the background of arterial hypertension were examined. Prognostic significance of GDF 15...
Saved in:
| Main Authors: | V. D. Syvolap, Ya. V. Zemlyaniy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2014-06-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/25596/23062 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic value of GDF levels 15 and NTproBNP and echocardiographic parameters in patients with heart failure with preserved ejection fraction, after myocardial infarction on the background of hypertension according to the three-year observation
by: V. D. Syvolap, et al.
Published: (2015-10-01) -
Comparative evaluation of the impact of candesartan and ramipril therapy on the levels of GDF 15 and NTproBNP, structural and functional performance of the heart in patients with coronary artery disease with asymptomatic diastolic dysfunction after myocar
by: V. D. Syvolap, et al.
Published: (2014-04-01) -
Dynamics of structural and functional changes of the heart and the levels of GDF 15 and NTproBNP on the candesartan and ramipril therapy in patients with heart failure with preserved ejection fraction after myocardial infarction on the background of arter
by: Ya. V. Zemlyaniy
Published: (2014-04-01) -
Features of cardiac remodeling and GDF 15 and NTproBNP levels in patients with heart failure and preserved ejection fraction depending on the history of myocardial infarction
by: Ya. V. Zemlianyi, et al.
Published: (2024-10-01) -
Biomarker NTproBNP in Patients with Severe CommunityAcquired Pneumonia
by: I. A. Kozlov, et al.
Published: (2016-07-01)